Overexpression of EZH2 in conjunctival melanoma offers a new therapeutic target

Autor: Cao, J.F., Pontes, K.C.S., Heijkants, R.C., Brouwer, N.J., Groenewoud, A., Jordanova, E.S., Marinkovic, M., Duinen, S. van, Teunisse, A.F.A.S., Verdijk, R.M., Snaar-Jagalska, E., Jochemsen, A.G., Jager, M.J.

Publikováno v: Journal of Pathology, 245(4), 433-444
Journal of Pathology, 245(4), 433-444. John Wiley & Sons Ltd.
Journal of Pathology, 245(4), 433-444. John Wiley and Sons Ltd
Cao, J, Pontes, K C, Heijkants, R C, Brouwer, N J, Groenewoud, A, Jordanova, E S, Marinkovic, M, van Duinen, S, Teunisse, A F, Verdijk, R M, Snaar-Jagalska, E, Jochemsen, A G & Jager, M J 2018, ' Overexpression of EZH2 in conjunctival melanoma offers a new therapeutic target ', Journal of Pathology, vol. 245, no. 4, pp. 433-444 . https://doi.org/10.1002/path.5094

Malignant melanoma of the conjunctiva (CM) is an uncommon but potentially deadly disorder. Many malignancies show an increased activity of the epigenetic modifier enhancer of zeste homolog 2 (EZH2). We studied whether EZH2 is expressed in CM, and whe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::09933add92d0e8ee5f804d1446950a6a
https://hdl.handle.net/1887/75936

Dystrophin levels do not influence disease progression in Becker muscular dystrophy patients with an exon 45-47 deletion

Autor: Bergen, J. van den, Wokke, B., Duinen, S. van, Ginjaar, H., Janson, A., Deutekom, J. van, Aartsma-Rus, A., Kan, H., Verschuuren, J.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f453d2bb35a2c7b9d9b4b6af502bb57d
https://hdl.handle.net/1887/96640